William, Doreen Mullins, Christina Schneider, Björn Orthmann, Andrea Lamp, Nora Krohn, Mathias Hoffmann, Annika Classen, Carl-Friedrich Linnebacher, Michael MOESM5 of Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies Additional file 5. GFAP Immunohistochemistry staining of paraffin embedded GBM and PDX tissue sections. A) HROG33 primary GBM, stained with new fuchsine B) HROG33 PDX after first in vivo transfer, C) HROG33 PDX after second in vivo transfer, D) HROG59 primary GBM, E) HROG59 PDX after first in vivo transfer, F) HROG59 PDX after second in vivo transfer. 200-fold magnification B-F were stained with 3,3′-Diaminobenzidine. Glioblastoma multiforme;PDX;Preclinical mouse models;Therapy;Engraftment rate 2017-02-09
    https://springernature.figshare.com/articles/presentation/MOESM5_of_Optimized_creation_of_glioblastoma_patient_derived_xenografts_for_use_in_preclinical_studies/4640341
10.6084/m9.figshare.c.3688192_D2.v1